May 2023 - Saturn Partners

Areteia Therapeutics Announces Start of Phase III Clinical Trials of Oral Dexpramipexole in Eosinophilic Asthma

Posted on May 18, 2023 at 10:40 am.

CHAPEL HILL, N.C.–(BUSINESS WIRE)–Areteia Therapeutics announced today that the first patients have been dosed in both the EXHALE-2 and EXHALE-4 trials as part of its overall Phase III clinical program investigating the efficacy and safety of oral dexpramipexole in severe … Continued

Yieldstreet and Equity Trust Announce Strategic Partnership to Expand IRA Access to Private Markets

Posted on May 2, 2023 at 10:34 am.

Written by saturnadmin

New WealthBridge platform makes adding alternative investments to retirement accounts as easy as buying a stock. NEW YORK, (BUSINESS WIRE) — Yieldstreet, the leading private market investing platform, and Equity Trust, one of the largest self-directed IRA custodians in the U.S., announced … Continued

Monthly Archives: May 2023